NASDAQ NMS - GLOBAL MARKET · SUPN

+1.35% · +$0.6400 · Vol Not reported

Market closed · last close 4:00 PM ET · price as of 16:00:00 ET

Supernus Pharmaceuticals Inc

Pharmaceuticals

$48.05

+ Add to watchlist

Card

Veridion Score

Refresh

Score snapshot refresh in progress

Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS

REFRESHES DAILY

AI Analysis

Sovereign

Why is SUPN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

About Supernus Pharmaceuticals Inc

PHARMACEUTICAL PREPARATIONS

Listed since

2012

Employees

778

Country

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$47.49

Day high

$48.11

Day low

$46.97

Previous close

$47.41

52W high

$48.11

-0.12% from high

52W low

$46.97

95% of range

Market cap

$2.8B

EPS

$-0.6500

Shares out

58M

VWAP

$47.41

Last session

Price history computed in-house

SMA 50 Not reported · Not reported

SMA 200 Not reported · Not reported

52W position 95%

Veridion warehouse edge

Warehouse intelligence for SUPN.

Veridion Score

Not reported

Congress 30d

No recent disclosure on file.

Insider activity

See Form 4 panel below.

13F holders

None on file

Capital Web snapshots checked.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.

Data ledger

Quote and day range

Refresh interval: 30 seconds

Source: Market data

Veridion Score

Coverage building

Source: Veridion methodology

Chart and risk context

Daily bars with no missing-bar fill

Source: Market data

News and filings

Refresh intervals shown inside each panel

Source: Market news and federal filings

Financials

Statements refresh in progress

SEC Form 4 ledger

SUPN insider activity

Supernus Pharmaceuticals Inc

Score

Coverage building

Pressure

Net selling

Filings

Buys / sells

24 / 58

Net value

-$12.8M

Insiders

Named filers

Bhatt Padmanabh P.

Insider

Leadership

Khattar Jack A.

Insider

Leadership

Hudson Frederick M.

Insider

Leadership

Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$12.8M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing date	Trade date	Insider	Title	Type	Price	Qty	Owned	Value	Receipt
2026-03-18	2026-03-18	Bhatt Padmanabh P.	Insider	sell	$50.48	412	17,044	$21K	SEC Form 4
2026-03-18	2026-03-18	Bhatt Padmanabh P.	Insider	sell	$49.55	6,838	17,456	$339K	SEC Form 4
2026-03-18	2026-03-18	Bhatt Padmanabh P.	Insider	buy	$39.40	7,250	24,294	$286K	SEC Form 4
2026-03-18	2026-03-17	Bhatt Padmanabh P.	Insider	sell	$50.73	22,290	17,044	$1.1M	SEC Form 4
2026-03-18	2026-03-17	Bhatt Padmanabh P.	Insider	sell	$49.95	27,710	39,334	$1.4M	SEC Form 4